Monday, October 05, 2015 6:58:43 PM
https://clinicaltrials.gov/ct2/show/NCT02493361?term=UCSF+and+keytruda&rank=2
Dr. Pierce convinced the FDA that $ONCS Phase1/2A very positive results were worthy of a Phase2B Combo with a FDA Commercially approved immunotherapy drug such as MRK's Keytruda. Despite the fact that the Combo had never before been tested in Phase1/2A safety/tolerability clinical trials. The FDA agreed and the 41 person P2B trial are already being recruited and trialed.
Many thxs again to Dr. Pierce.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM